(Q44583525)

4 December 2017

Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy). (English)

1 reference

4 December 2017

1 reference

1 reference

1 reference

Kleiner RC

1

1 reference

4 December 2017

Najarian LV

2

1 reference

4 December 2017

Schatten S

3

1 reference

4 December 2017

Jabs DA

4

1 reference

4 December 2017

Patz A

5

1 reference

4 December 2017

Kaplan HJ

6

1 reference

4 December 2017

language of work or name

1 reference

1 June 1989

1 reference

4 December 2017

1 reference

4 December 2017

96

1 reference

4 December 2017

6

1 reference

4 December 2017

896-904

1 reference

Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Possible relationship between lupus inhibitor and recurrent abortion in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Lupus anticoagulant and pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Lupus anticoagulant and thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

An unusual syndrome of a devastating noninflammatory vasculopathy associated with anticardiolipin antibodies: report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Antiphospholipid antibodies associated with retinal vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Recurrent ischemic attacks in two young adults with lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Visual symptoms associated with the presence of a lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

A Sensitive Test Demonstrating Lupus Anticoagulant and its Behavioural Patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

The lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Demonstration of a platelet bypass mechanism in the clotting system using an acquired anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Anticardiolipin antibodies and lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Thrombosis in patients with the lupus anticoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Myocardial infarction in systemic lupus erythematosus and "lupus-like" disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Retinopathy in systemic lupus erythematosus. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Central retinal artery occlusion

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Retinopathy in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Retinal arterial occlusive disease in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Central retinal vein occlusion complicating systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Visual Loss as the Initial Symptom of Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

SLE retinopathy: evaluation by fluorescein angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Unilateral systemic lupus erythematosus retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Proliferative lupus retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Cerebral and retinal vascular changes in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Myocardial infarction with central retinal artery occlusion in a patient with antinuclear antibody-negative systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Severe retinal vaso-occlusive disease in systemic lupus erythematous

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

Anticardiolipin antibody, recurrent thrombosis, and warfarin withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2889%2932825-9

7 January 2021

10.1016/S0161-6420(89)32825-9

Identifiers

DOI

1 reference

4 December 2017

1 reference